Cardio Diagnostics Holdings Inc. - CDIO Net earnings per share for the last four quarters

Public company logo of Cardio Diagnostics Holdings, Inc. (CDIO)

The GURU.Markets terminal provides a chart of the annual net income per share TTM trend, where the value 34.90 characterizes this level. The growth of Cardio Diagnostics (CDIO) relies on the demand for epigenetic tests and the expansion of insurance coverage. A scalable cloud IT infrastructure ensures uninterrupted data analysis, while unique AI diagnostic technologies enable the company to exercise pricing power through premium service rates.

CDIO Cardio Diagnostics Holdings: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/12/2026

CDIO (Cardio Diagnostics Holdings, Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:
Market Chart Cardio Diagnostics|CDIO - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Cardio Diagnostics Holdings Inc.|CDIO - Total Company Value
- book value of equity indicators:
Net Assets per Share Cardio Diagnostics|CDIO - Book Capitalization|Market Cap to Net Assets Ratio cardiodiagnosticsinc.com|CDIO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Cardio Diagnostics|CDIO - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Cardio Diagnostics|CDIO - Company Aggregate Debts|Debt to Book Value Ratio Cardio Diagnostics Holdings Inc.|CDIO - Company Long-Term Debts|Short-Term Debt Volume Cardio Diagnostics|Immediate Liquidity cardiodiagnosticsinc.com
- business earnings and investment ratios data:
CDIO - Net Income|Expected Net Income Cardio Diagnostics|CDIO - P/E Multiple|Price to Future Earnings Ratio Cardio Diagnostics|CDIO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Cardio Diagnostics Holdings Inc.|CDIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Cardio Diagnostics|CDIO - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year cardiodiagnosticsinc.com|CDIO - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cardio Diagnostics
Fundamental company valuation:Cardio Diagnostics Holdings, CDIO
Mass-produced product of cardiodiagnosticsinc.com

For Cardio Diagnostics (CDIO), the YoY EPS volatility over the last 12 months reflects the impact of geopolitical fragmentation on the export of diagnostic systems. This metric measures the annual growth rate of net income per share over a rolling period. The calculation is based on a comparison of current aggregate earnings with the equivalent window from the previous year. This trend captures the sensitivity of profitability to logistic disruptions in reagent supplies. The growth of this metric confirms the effectiveness of business scaling amidst market isolation.

Competitor analysis for Cardio Diagnostics

Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share for the last 12 months anbio.com NNNN|Net earnings per share (EPS TTM) SHC (Sotera Health)|Net earnings per share (EPS TTM) Quidel Corporation QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (CareDx, Inc)|MRVI: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months FLGT|LAB (Standard BioTools) - Net earnings per share (EPS TTM)|Cytek Biosciences Inc (CTKB) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months OraSure Technologies Inc (OSUR)|XGN - Net earnings per one share for the last twelve months|MDxHealth SA - Net earnings per share for the last 12 months|Earnings per share for the trailing year LUCD|Prenetics Global Ltd - Net earnings per share (EPS TTM)|IMDX (Insight Molecular Diagnostics) - Earnings per share for the last 12 months|TRIB: Net earnings per share (EPS TTM)|PRPH - Net earnings per share for the last four quarters|AIMD (Ainos, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) codiagnostics.com|Net earnings per share (EPS TTM) HSCS|Biomerica Inc. (BMRA) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix Corp ONCO|VRAX: Earnings per share for the last 12 months|BJDX - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months aspirawh.com|Accelerate Diagnostics, Inc. (AXDX) - Earnings per share for the last twelve months|CNTG - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ENZ|FRES (Fresh2) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) GENE|Net earnings per share for the last four quarters 23andme.com|Net earnings per share (EPS TTM) PMD (Psychemedics Corporation)